BOSTON, July 02, 2025 — Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, today announced continuation of support from the Rapid Acceleration of Diagnostics (RADx®) program after completing all milestones under its existing RADx program of work to support the development of a molecular respiratory at-home diagnostic. This additional support will enable Sapphiros to build upon the initial program of work, supporting manufacturing transfer and clinical readiness activities of a low-cost, disposable, connected diagnostic device. This cutting-edge solution integrates Sapphiros’ proprietary isothermal molecular chemistries, sensing technologies, conductive inks, and high-volume reel-to-reel printed electronics.
The Sapphiros molecular platform represents a breakthrough in consumer diagnostics, bringing laboratory-quality molecular detection into the home, with a single user step and easy to read digital results. For the first time, consumers will be able to access high performance, easy to use, molecular technology typically available only in clinical settings. This breakthrough addresses a critical gap in consumer health, making advanced diagnostics both practical and attainable outside of traditional healthcare settings.
“The continued support from RADx validates the progress we have made towards a consumer molecular diagnostic platform,” said Mark Gladwell, CEO of Sapphiros. “The respiratory multiplex product is the first of a broad and exciting pipeline of molecular consumer tests.”
This project has been partly funded with federal funds from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health, Department of Health and Human Services, under Contract No. 75N92023D00001.
About Sapphiros
Sapphiros, backed by KKR and Neoenta, is a privately held consumer diagnostics company. Sapphiros’s portfolio of capabilities and technologies includes novel sample collection, next-generation diagnostics, computational biology and printed electronics, which help consumers access important diagnostic results globally. Knowing Now Moves Us™.
For more information, contact Sapphiros at press@sapphiros.com.